Novartis Ag (NVS) Goodwill & Intangibles (2009 - 2026)

Novartis Ag (NVS) posted Goodwill & Intangibles of $12.7 billion for Q1 2026, down 76.9% sequentially from $55.0 billion in Q4 2025.

Novartis Ag (NVS) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Novartis Ag (NVS) has 14 years of Goodwill & Intangibles data on file, last reported at $12.7 billion in Q1 2026.

  • Quarterly Goodwill & Intangibles changed N/A year-over-year to $12.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.7 billion (changed N/A YoY) and the FY2025 annual result came in at $55.0 billion, up 6.4% from the prior year.
  • Goodwill & Intangibles eased to $12.7 billion in Q1 2026 per NVS's latest filing, from $55.0 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $81.7 billion in Q4 2023, with the low at $162.0 million in Q3 2022.
  • Average Goodwill & Intangibles over 5 years is $35.9 billion, with a median of $51.7 billion recorded in 2024.
  • Year-over-year, Goodwill & Intangibles sank 62.76% in 2022 and surged 4795.74% in 2023.
  • Novartis Ag's Goodwill & Intangibles stood at $26.7 billion in 2022, then soared by 206.21% to $81.7 billion in 2023, then sank by 36.72% to $51.7 billion in 2024, then increased by 6.4% to $55.0 billion in 2025, then sank by 76.9% to $12.7 billion in 2026.
  • Business Quant data shows NVS's Goodwill & Intangibles at $12.7 billion in Q1 2026, $55.0 billion in Q4 2025, and $54.8 billion in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.70 Bn
Dec 31, 2025 54.98 Bn
Jun 30, 2025 54.79 Bn
Dec 31, 2024 51.67 Bn
Jun 30, 2024 53.01 Bn
Dec 31, 2023 81.66 Bn
Jun 30, 2023 57.53 Bn
Dec 31, 2022 26.67 Bn
Sep 30, 2022 162.00 Mn
Jun 30, 2022 1.18 Bn
Dec 31, 2021 27.19 Bn
Sep 30, 2021 435.00 Mn
Jun 30, 2021 257.00 Mn
Mar 31, 2021 235.00 Mn
Dec 31, 2020 3.43 Bn
Sep 30, 2020 218.00 Mn
Jun 30, 2020 10.11 Bn
Dec 31, 2019 7.62 Bn
Jun 30, 2019 486.00 Mn
Mar 31, 2019 539.00 Mn